Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Molecular Partners AG
MOLNCurrent price
4.85 CHF
-0.15 CHF (-2.90%)
Last closed
5.2 CHF
Company
www.molecularpartners.com
ISIN
CH0256379097
Sector
Healthcare
Industry
Biotechnology
Exchange
SIX Swiss Exchange
Capitalization
205 550 344 CHF
Yield for 12 month
+21.25 %
1Y
3Y
5Y
10Y
15Y
MOLN
Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia. It also develops Switch-DARPin platform, a multispecific cKIT x CD16a x CD47 Switch-DARPin program for targeted and conditional immune cell activation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has license and research collaboration agreements with Novartis Pharma AG to develop DARPin-conjugated radioligand therapies; and collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland. Address: Wagistrasse 14, Schlieren, Switzerland, 8952
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.79 CHFP/E ratio
–Dividend Yield
–Current Year
+7 114 496 CHF
Last Year
+191 616 284 CHF
Current Quarter
+688 402 CHF
Last Quarter
+1 567 858 CHF
Current Year
-41 249 521 CHF
Last Year
+140 315 693 CHF
Current Quarter
+688 402 CHF
Last Quarter
-11 661 385 CHF
Key Figures MOLN
1 year
3 years
5 years
10 years
EBITDA
-62 837 639 CHF
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-21.17 %
PEG Ratio
–
Return On Equity TTM
-37.37 %
Wall Street Target Price
9.79 CHF
Revenue TTM
6 067 236 CHF
Book Value
4.23 CHF
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-73.2 %
Dividend Yield
–
Gross Profit TTM
140 360 171 CHF
Earnings per share
-1.91 CHF
Diluted Eps TTM
-1.91 CHF
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MOLN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MOLN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MOLN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
13.624
Enterprise Value Revenue
10.4081
Price Sales TTM
33.8787
Enterprise Value EBITDA
1.1235
Price Book MRQ
1.4652
Financials MOLN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MOLN
For 52 weeks
3.14 CHF
9.6 CHF
50 Day MA
4.72 CHF
Shares Short Prior Month
–
200 Day MA
4.62 CHF
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart